Luffa Khnom-Ramsden

Article | By Will Staddon, Pelican BioThermal Passive bulk shippers offer pharmaceutical companies solutions to the regulatory hurdles, supply chain disruptions, and logistical challenges inherent to global commercial pharmaceutical transport. Article | By Luffa Khnom-Ramsden, T-FIT A fungal contamination outbreak can result in everything from product recalls, with the associated reputational brand damage and production downtime, through to actual harm to patients’ health.

By Luffa Khnom-Ramsden Fungal contamination, most commonly by moulds and yeasts, is bad news for cleanroom manufacturing of pharmaceuticals. An outbreak can result in everything from product recalls, with the associated reputational brand damage, and production downtime through to actual harm to patients’ health. From a production point of view, the relatively common fungus Aspergillus niger is known to contaminate raw materials stored in coldrooms prior to cleanroom manufacture.